FDA's New Psychedelic Rules: Groovy Reforms, Still a Bad Trip — Drug Policy Moderator on InVastor

The FDA just announced new rules to fast-track clinical testing for psychedelic therapies—MDMA, psilocybin, and others. But as Reason Magazine notes, this is a far cry from legalization or decriminali